Literature DB >> 11522846

Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.

A V Lichtenstein1, O I Serdjuk, T I Sukhova, H S Melkonyan, S R Umansky.   

Abstract

The enriched PCR widely used for detection of mutant K-RAS in either tumor tissues or circulating DNA was modified so that abundant wild-type K-RAS alleles are cleaved prior to PCR. We took advantage of an AluI recognition site located immediately upstream of the K-RAS codon 12. The site was reconstituted upon DNA denaturation followed by annealing with a 'stencil', a 16-bp synthetic oligonucleotide complementary to the wild-type sequence. As opposed to normal K-RAS, the mutant allele forms, upon annealing with the stencil, a mismatch at the codon 12 which lies within the AluI enzyme binding site and partially inhibits its activity. The mismatch also lowers the melting temperature of the stencil-mutant K-RAS double helix as compared to stencil-wild-type duplex, so that only the latter is double stranded and selectively digested by AluI at elevated temperatures. The proposed method of stencil-aided mutation analysis (SAMA) based on selective pre-PCR elimination of wild-type sequences can be highly advantageous for detection of mutant K-RAS due to: (i) an enhanced sensitivity because of reduced competition with a great excess of normal K-RAS, and (ii) a decrease in a number of false-positive results from Taq polymerase errors. Application of SAMA for generalized detection of DNA mutations is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522846      PMCID: PMC55902          DOI: 10.1093/nar/29.17.e90

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Removal of polymerase-produced mutant sequences from PCR products.

Authors:  J Smith; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

2.  Enrichment polymerase chain reaction for the detection of Ki-ras mutations: relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands.

Authors:  G Jacobs; E Tscholl; A Sek; M Pfreundschuh; H Daus; L Trümper
Journal:  J Cancer Res Clin Oncol       Date:  1999-07       Impact factor: 4.553

3.  Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.

Authors:  Y Yamaguchi; H Watanabe; S Yrdiran; K Ohtsubo; Y Motoo; T Okai; N Sawabu
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

4.  XcmI as a universal restriction enzyme for single-stranded DNA.

Authors:  P C Shaw; Y K Mok
Journal:  Gene       Date:  1993-10-29       Impact factor: 3.688

5.  Microsatellite alterations in plasma DNA of small cell lung cancer patients.

Authors:  X Q Chen; M Stroun; J L Magnenat; L P Nicod; A M Kurt; J Lyautey; C Lederrey; P Anker
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

6.  Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.

Authors:  S A Ahrendt; J T Chow; L H Xu; S C Yang; C F Eisenberger; M Esteller; J G Herman; L Wu; P A Decker; J Jen; D Sidransky
Journal:  J Natl Cancer Inst       Date:  1999-02-17       Impact factor: 13.506

7.  A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.

Authors:  H E Mulcahy; J Lyautey; C Lederrey; X qi Chen; P Anker; E M Alstead; A Ballinger; M J Farthing; M Stroun
Journal:  Clin Cancer Res       Date:  1998-02       Impact factor: 12.531

8.  Detection of tumour DNA in serum of colorectal cancer patients.

Authors:  J B de Kok; W W van Solinge; T J Ruers; R W Roelofs; G N van Muijen; J L Willems; D W Swinkels
Journal:  Scand J Clin Lab Invest       Date:  1997-11       Impact factor: 1.713

9.  Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

Authors:  T Yamada; S Nakamori; H Ohzato; S Oshima; T Aoki; N Higaki; K Sugimoto; K Akagi; Y Fujiwara; I Nishisho; M Sakon; M Gotoh; M Monden
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

10.  Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.

Authors:  M S Kopreski; F A Benko; C Kwee; K E Leitzel; E Eskander; A Lipton; C D Gocke
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  2 in total

1.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Authors:  Karl Sotlar; Luis Escribano; Olfert Landt; Stefanie Möhrle; Sonia Herrero; Antonio Torrelo; Ulrich Lass; Hans-Peter Horny; Burkhard Bültmann
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Restriction endonuclease-catalyzed cleavage of DNA stimulates subsequent polymerase chain reaction and enables discrimination between normal and mutant K-RAS alleles.

Authors:  I V Botezatu; O I Serdyuk; G I Potapova; V P Shelepov; A V Likhtenshtein
Journal:  Dokl Biochem Biophys       Date:  2003 Nov-Dec       Impact factor: 0.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.